Asia Pharmaceuticals and Healthcare Report - Business Monitor International - Industry Reports

Asia Pharmaceuticals and Healthcare Report

Asia Pharmaceuticals and Healthcare Report - Business Monitor International - Industry Reports
Asia Pharmaceuticals and Healthcare Report
Published Oct 22, 2016
40 pages — Published Oct 22, 2016
Price US$ 1,295.00  |  Buy this Report Now

About This Report

  
Abstract:

----, though we note that the USD--bn (EUR--bn) Australia and New Zealand markets will experience a more modest growth rate through to ---- at a -.- CAGR. Growth forecasts are in local currency terms that are aggregated from the country-level US dollar proportions, which have been equalised to minimise currency fluctuations using a time series-weighted calculation. ...Representing a highly heterogeneous region, the steady growth in medicine sales across the region will come from the confluence of rising purchasing power and improving healthcare access. In particular, the rollout of universal healthcare across the emerging markets is expected to present substantial revenue- earning opportunities for pharmaceutical companies as financial burdens are alleviated and patients gain access to risk pooling. A threat to this outlook stems from the use of cost-containment measures as governments seek to develop their healthcare system while rationalising spending. ...A threat to this outlook stems from the use of cost-containment measures as governments seek to develop their healthcare system while rationalising spending.

...� Business Monitor International Ltd Page -- aggregated from country-level US dollar proportions, which have been equalised to minimise currency fluctuations using a time series-weighted calculation. Asia s overall healthcare market will post a five-year CAGR of -.- in USD terms and -.- in EUR terms. ...Chronic diseases are on the rise across the region as the aged population grows and as lifestyles shift in tandem with higher levels of urbanisation. In addition, several markets have implemented or intend to roll out universal healthcare, which will alleviate financial barriers to medical services and increase utilisation rates. This in turn incentivises private healthcare providers to be more active, establishing clinics or hospitals in Asia, and increases participation in the medical tourism industry. ...This in turn incentivises private healthcare providers to be more active, establishing clinics or hospitals in Asia, and increases participation in the medical tourism industry.

...BMI View: The Asia Pacific healthcare sector s growth trajectory will be decidedly positive. The expansion of universal healthcare across the region will boost utilisation of medical services even as the prevalence of chronic diseases rise in tandem with the shift in lifestyles and an ageing population. ...

  
Source:
Document ID
2398-1016
Industry
Format:
PDF Adobe Acrobat
Buy Now

Business Monitor International - Industry Reports—Established in 1984, Business Monitor International is a leading online publisher of specialist business information on global emerging markets. Business Monitor's range of quarterly services covers political risk, finance, macroeconomic performance, outlook and forecast, industry sectors and the business operating environment. Each Industry Report has been researched at source, and features latest-available data covering production, sales, imports and exports; 5-year industry forecasts through end-2012; company rankings and competitive landscapes for multinational and local manufacturers and suppliers; and analysis of latest industry developments, trends and regulatory changes.

About the Author


Cite this Report

  
MLA:
Business Monitor International - Industry Reports. "Asia Pharmaceuticals and Healthcare Report" Oct 22, 2016. Alacra Store. Dec 02, 2016. <http://www.alacrastore.com/storecontent/Business-Monitor-International-Industry-Reports/Asia-Pharmaceuticals-and-Healthcare-Report-2026-1995>
  
APA:
Business Monitor International - Industry Reports. (2016). Asia Pharmaceuticals and Healthcare Report Oct 22, 2016. New York, NY: Alacra Store. Retrieved Dec 02, 2016 from <http://www.alacrastore.com/storecontent/Business-Monitor-International-Industry-Reports/Asia-Pharmaceuticals-and-Healthcare-Report-2026-1995>
  
US$ 1,295.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Market Research from one place.